Global Cryopreservation for In-Vitro Fertilization (IVF) Market Report and Forecast 2024-2032
Global Cryopreservation for In-Vitro Fertilization (IVF) Market Outlook
The global cryopreservation for in-vitro fertilization (IVF) is expected to grow at a CAGR of 10.6% during the forecast period of 2024-2032.
Cryopreservation for In-Vitro Fertilization (IVF): Introduction
Cryopreservation for in-vitro fertilization (IVF) is a critical component of modern assisted reproductive technology (ART) that allows the freezing and preservation of reproductive materials such as eggs, sperm, and embryos for future use in fertility treatments. This technology has revolutionized the field of reproductive medicine, offering new possibilities to individuals and couples facing fertility challenges. cryopreservation for IVF is a transformative technology that has expanded the possibilities for fertility preservation, assisted reproduction, and family building. It has become an integral part of modern reproductive medicine, offering hope and options to individuals and couples on their journey to parenthood. The availability and affordability of cryopreservation services have improved, making fertility preservation and IVF more accessible to a broader range of individuals and couples.
Key Trends in the Global Cryopreservation for In-Vitro Fertilization (IVF) Market
The cryopreservation for in-vitro fertilization (IVF) market has been experiencing significant growth and evolution in recent years. Several key trends are some key trends shaping the market:
- Fertility Preservation for Women: An increasing number of women are choosing to freeze their eggs for fertility preservation. This trend is driven by delayed childbearing, career considerations, and advancements in egg freezing technology.
- Single Embryo Transfer (SET): To reduce the risk of multiple pregnancies and associated complications, IVF clinics are moving towards SET, where a single embryo is transferred, and the remaining high-quality embryos are cryopreserved for future use.
- Globalization of Cryopreservation Services: Cryopreservation banks and IVF clinics are expanding their services internationally. This trend allows patients to access donor gametes and reproductive materials from around the world, increasing their options for assisted reproduction.
- Donor Gametes and Embryo Adoption: The availability of cryopreserved donor sperm, eggs, and embryos is increasing. This has facilitated assisted reproduction for individuals and couples who require donor materials, contributing to a growing global market for these services.
The market can be categorized type, application, end user, and region.
Market Breakup by Type
- Cryopreservation Media
- Cryopreservation Storage Devices
- Consumables
- Accessories
- Cryo-shipping
- Others
- Oocyte Cryopreservation
- Sperm Cryopreservation
- Embryo Cryopreservation
- Others
- Biobanks
- IVF Centres
- Fertility Clinics
- Research and Academic Institutes
- Cryo-shipping/ Couriers
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The global cryopreservation for in-vitro fertilization (IVF) market is an integral part of the assisted reproductive technology (ART) industry. Cryopreservation techniques have transformed the field of reproductive medicine by allowing the freezing and storage of reproductive materials, such as eggs, sperm, and embryos, for future use in fertility treatments. The global cryopreservation for IVF market has experienced significant growth and is projected to continue expanding in the coming years.
Factors contributing to market growth include increasing infertility rates, delayed childbearing, advancements in cryopreservation technology, and the growing demand for assisted reproductive treatments. the global cryopreservation for IVF market is vital in assisting individuals and couples in their journey to parenthood. The adoption of cryopreservation technology, along with advancements in IVF treatments, has expanded the possibilities for fertility preservation and family building. As the demand for assisted reproductive technologies continues to grow, the cryopreservation for IVF market is expected to see further development and innovation in the years to come.
Key Players in the Global Cryopreservation for In-Vitro Fertilization (IVF) Market
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in global cryopreservation for in-vitro fertilization (IVF) market are as follows:
- Cryotech
- Cook Medical LLC
- Fujifilm Irvine Scientific
- Thermo Fisher Scientific Inc
- Coldstash Inc.
- Vitromed GmbH
- Corning Incorporated
- Cryogatt Systems Ltd
- Brook Life Sciences
- Cryo Solutions B.V.
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Cryopreservation for in-vitro fertilization (IVF) market Overview
- 3.1 Global Cryopreservation for in-vitro fertilization (IVF) market Historical Value (2017-2023)
- 3.2 Global Cryopreservation for in-vitro fertilization (IVF) market Forecast Value (2024-2032)
- 4 Global Cryopreservation for in-vitro fertilization (IVF) market Landscape
- 4.1 Global Cryopreservation for in-vitro fertilization (IVF): Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Cryopreservation for in-vitro fertilization (IVF): Product Landscape
- 4.2.1 Analysis by End User
- 4.2.2 Analysis by Type
- 4.2.3 Analysis by Applications
- 5 Global Cryopreservation for in-vitro fertilization (IVF) market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Cryopreservation for in-vitro fertilization (IVF) market Segmentation
- 6.1 Global Cryopreservation for in-vitro fertilization (IVF) market by Type
- 6.1.1 Market Overview
- 6.1.2 Cryopreservation Media
- 6.1.3 Cryopreservation Storage Devices
- 6.1.4 Consumables
- 6.1.5 Accessories
- 6.1.6 Cryo-shipping
- 6.1.7 Others
- 6.2 Global Cryopreservation for in-vitro fertilization (IVF) market by Applications
- 6.2.1 Market Overview
- 6.2.2 Oocyte Cryopreservation
- 6.2.3 Sperm Cryopreservation
- 6.2.4 Embryo Cryopreservation
- 6.2.5 Others
- 6.3 Global Cryopreservation for in-vitro fertilization (IVF) market by End User
- 6.3.1 Market Overview
- 6.3.2 Biobanks
- 6.3.3 IVF
- 6.3.4 Fertility Clinics
- 6.3.5 Research and Academic Institutes
- 6.3.6 Cryo-shipping/ Couriers
- 6.4 Global Cryopreservation for in-vitro fertilization (IVF) market by Region
- 6.4.1 Market Overview
- 6.4.2 North America
- 6.4.3 Europe
- 6.4.4 Asia Pacific
- 6.4.5 Latin America
- 6.4.6 Middle East and Africa
- 7 North America Cryopreservation for in-vitro fertilization (IVF) market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Cryopreservation for in-vitro fertilization (IVF) market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Cryopreservation for in-vitro fertilization (IVF) market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Cryopreservation for in-vitro fertilization (IVF) market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Cryopreservation for in-vitro fertilization (IVF) market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Regulatory Framework
- 12.1 Regulatory Overview
- 12.1.1 US FDA
- 12.1.2 EU EMA
- 12.1.3 INDIA CDSCO
- 12.1.4 JAPAN PMDA
- 12.1.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 13.7 Analysis by Key Players
- 14 Grants Analysis
- 14.1 Analysis by year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Application
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by NIH Departments
- 14.7 Analysis by Recipient Organization
- 15 Funding and Investment Analysis
- 15.1 Analysis by Funding Instances
- 15.2 Analysis by Type of Funding
- 15.3 Analysis by Funding Amount
- 15.4 Analysis by Leading Players
- 15.5 Analysis by Leading Investors
- 15.6 Analysis by Geography
- 16 Partnership and Collaborations Analysis
- 16.1 Analysis by Partnership Instances
- 16.2 Analysis by Type of Partnership
- 16.3 Analysis by Leading Players
- 16.4 Analysis by Geography
- 17 Supplier Landscape
- 17.1 Cryotech
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 Cook Medical LLC
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Fujifilm Irvine Scientific
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Thermo Fisher Scientific Inc
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 Coldstash Inc.
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Vitromed GmbH
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 Corning Incorporated
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Cryogatt Systems Ltd
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Brook Life Sciences
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 Cryo Solutions B.V.
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 18 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 19 Company Competitiveness Analysis (Additional Insight)
- 19.1 Very Small Companies
- 19.2 Small Companies
- 19.3 Mid-Sized Companies
- 19.4 Large Companies
- 19.5 Very Large Companies
- 20 Payment Methods (Additional Insight)
- 20.1 Government Funded
- 20.2 Private Insurance
- 20.3 Out-of-Pocket
- *Additional insights provided are customisable as per client requirements.
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook